| 1 | international | 9,309 |
| 2 | interagency | 41 |
| 3 | brighton | 13 |
| 4 | french-american-british | 11 |
| 5 | national/international | 11 |
| 6 | pharmetrics | 11 |
| 7 | intercontinental | 10 |
| 8 | centrewatch | 8 |
| 9 | well-publicized | 8 |
| 10 | accrediting | 7 |
| 11 | eaaci | 7 |
| 12 | ensembl | 7 |
| 13 | non-medline | 7 |
| 14 | time-cycled | 7 |
| 15 | ambrosetti | 6 |
| 16 | ash/asco | 6 |
| 17 | fife | 6 |
| 18 | ich-gcp | 6 |
| 19 | licl-induced | 6 |
| 20 | qualis | 6 |
| 21 | haddad | 5 |
| 22 | industry-independent | 5 |
| 23 | pennington | 5 |
| 24 | wcrf/aicr | 5 |
| 25 | ats/ers/jrs/alat | 4 |
| 26 | essex-lopresti | 4 |
| 27 | folated | 4 |
| 28 | hohenheim | 4 |
| 29 | iuga-ics | 4 |
| 30 | jeog | 4 |
| 31 | kudo | 4 |
| 32 | morris-marshall | 4 |
| 33 | nuys | 4 |
| 34 | staff-derived | 4 |
| 35 | u.k.-based | 4 |
| 36 | 8-core | 3 |
| 37 | aocmf | 3 |
| 38 | ats/idsa | 3 |
| 39 | dharmarajan | 3 |
| 40 | eurocat | 3 |
| 41 | evans-jensen | 3 |
| 42 | expository | 3 |
| 43 | getgoal | 3 |
| 44 | gish | 3 |
| 45 | hew | 3 |
| 46 | hypolyte | 3 |
| 47 | idsa/ats | 3 |
| 48 | inter-national | 3 |
| 49 | oligarchic | 3 |
| 50 | patriotic | 3 |
| 51 | sepulveda | 3 |
| 52 | time/international | 3 |
| 53 | abbé | 2 |
| 54 | active-passive | 2 |
| 55 | ami-kyoto | 2 |
| 56 | amsterdam-maastricht | 2 |
| 57 | antares | 2 |
| 58 | cd3/cd28 | 2 |
| 59 | e-healing | 2 |
| 60 | e04 | 2 |
| 61 | eurofins | 2 |
| 62 | goh | 2 |
| 63 | heath-edwards | 2 |
| 64 | hospital/industry | 2 |
| 65 | italian-american | 2 |
| 66 | keith-wagener | 2 |
| 67 | longitudinale | 2 |
| 68 | lung-cell | 2 |
| 69 | multi-value | 2 |
| 70 | nci-sponsored | 2 |
| 71 | nidcr-funded | 2 |
| 72 | patient-choice | 2 |
| 73 | reichek | 2 |
| 74 | shimada | 2 |
| 75 | surgical-pathological | 2 |
| 76 | t2n1 | 2 |
| 77 | time-international | 2 |
| 78 | ukpid | 2 |
| 79 | who/isgyp | 2 |
| 80 | 'kanyini | 1 |
| 81 | 'salmeterol | 1 |
| 82 | -calmodulin | 1 |
| 83 | -european | 1 |
| 84 | -tonsillectomy | 1 |
| 85 | -wellbeing | 1 |
| 86 | 0.28±0.15 | 1 |
| 87 | 10,164 | 1 |
| 88 | 11-ketobetamethasone | 1 |
| 89 | 2,100bp | 1 |
| 90 | 3-staged | 1 |
| 91 | 42a | 1 |
| 92 | 450-page | 1 |
| 93 | 802.15.4 | 1 |
| 94 | 900-min | 1 |
| 95 | absorb-extend | 1 |
| 96 | actg-019 | 1 |
| 97 | adipogenically | 1 |
| 98 | african-centred | 1 |
| 99 | al-razi | 1 |
| 100 | algorithm-dependent | 1 |
| 101 | allo-transplantable | 1 |
| 102 | amduca | 1 |
| 103 | apodictic | 1 |
| 104 | arc/bsr | 1 |
| 105 | ase/eae | 1 |
| 106 | asfs-based | 1 |
| 107 | ash/ish | 1 |
| 108 | aspecct | 1 |
| 109 | atomix | 1 |
| 110 | aua/acs | 1 |
| 111 | autoset™ | 1 |
| 112 | bioinformatics-based | 1 |
| 113 | boost© | 1 |
| 114 | boryung | 1 |
| 115 | breath-actuator | 1 |
| 116 | böstman | 1 |
| 117 | cairui | 1 |
| 118 | cal/osha | 1 |
| 119 | canchild | 1 |
| 120 | care-hd | 1 |
| 121 | ccdc3-containing | 1 |
| 122 | cernea | 1 |
| 123 | chemo-induced | 1 |
| 124 | chius | 1 |
| 125 | cirs-053 | 1 |
| 126 | cochrane/trials | 1 |
| 127 | cohort—the | 1 |
| 128 | concertées | 1 |
| 129 | council/australasian | 1 |
| 130 | dejour | 1 |
| 131 | dhew | 1 |
| 132 | diminish-ing | 1 |
| 133 | disease-centred | 1 |
| 134 | eas/esc | 1 |
| 135 | eau/esiu | 1 |
| 136 | ebewe | 1 |
| 137 | efmann | 1 |
| 138 | efsumb | 1 |
| 139 | eight-class | 1 |
| 140 | erspc-affiliated | 1 |
| 141 | examiner-reported | 1 |
| 142 | existingcholesterol | 1 |
| 143 | friville | 1 |
| 144 | ftc/international | 1 |
| 145 | g=-3.36 | 1 |
| 146 | geographycally | 1 |
| 147 | gina/nih | 1 |
| 148 | glucksberg | 1 |
| 149 | grelan | 1 |
| 150 | grundartangi | 1 |
| 151 | guelrud | 1 |
| 152 | h-delta | 1 |
| 153 | hand-action | 1 |
| 154 | hemis | 1 |
| 155 | hf/hf-fed | 1 |
| 156 | hinkle | 1 |
| 157 | histogenic | 1 |
| 158 | hormone-naive | 1 |
| 159 | hospitals/ucl | 1 |
| 160 | hypertensive-hypercholesterolemic | 1 |
| 161 | ic3d | 1 |
| 162 | ideal32 | 1 |
| 163 | ihpba | 1 |
| 164 | iii-phase | 1 |
| 165 | isrctn16968287 | 1 |
| 166 | jackknifed | 1 |
| 167 | jetf | 1 |
| 168 | joints-the | 1 |
| 169 | kinase/phosphatase | 1 |
| 170 | klossner | 1 |
| 171 | koval | 1 |
| 172 | laporta | 1 |
| 173 | lasker-debakey | 1 |
| 174 | lasker~debakey | 1 |
| 175 | levels-national | 1 |
| 176 | lipididiet | 1 |
| 177 | m2182 | 1 |
| 178 | mechanismsof | 1 |
| 179 | mediafinder®-standard | 1 |
| 180 | medline/relevant | 1 |
| 181 | meshs | 1 |
| 182 | methyldopa+thiazides | 1 |
| 183 | micro-cares | 1 |
| 184 | micturition/international | 1 |
| 185 | morphological-based | 1 |
| 186 | movahed | 1 |
| 187 | msmart | 1 |
| 188 | mt-driven | 1 |
| 189 | murgo | 1 |
| 190 | nausea-induced | 1 |
| 191 | ncep-atp3 | 1 |
| 192 | nei-sponsored | 1 |
| 193 | nmes-evoked | 1 |
| 194 | nrtis+a | 1 |
| 195 | nsclc∶ | 1 |
| 196 | oncology-taiho | 1 |
| 197 | onycoe-t. | 1 |
| 198 | organisation-esmo-european | 1 |
| 199 | organisation-european | 1 |
| 200 | organises | 1 |
| 201 | overdiagnosis-themed | 1 |
| 202 | oyedeji | 1 |
| 203 | patient-simulated | 1 |
| 204 | pauwels | 1 |
| 205 | pharmachologically | 1 |
| 206 | pharmacuetical | 1 |
| 207 | phpt-2 | 1 |
| 208 | polimorphous | 1 |
| 209 | practice-selected | 1 |
| 210 | progesterone-rich | 1 |
| 211 | pseudonymous | 1 |
| 212 | pth-levels | 1 |
| 213 | racgp | 1 |
| 214 | rayhack | 1 |
| 215 | re-developed | 1 |
| 216 | re-search | 1 |
| 217 | region-appropriate | 1 |
| 218 | regnauld | 1 |
| 219 | resolute-korea | 1 |
| 220 | ridley-jopling | 1 |
| 221 | sakakibara | 1 |
| 222 | sakita-miwa | 1 |
| 223 | siopel-3 | 1 |
| 224 | six-randomized | 1 |
| 225 | slnb-based | 1 |
| 226 | smillie | 1 |
| 227 | standard-observer | 1 |
| 228 | still-evolving | 1 |
| 229 | stroke-funded | 1 |
| 230 | stulberg | 1 |
| 231 | taisho | 1 |
| 232 | task-force | 1 |
| 233 | theradoc™ | 1 |
| 234 | third-edition | 1 |
| 235 | timi-iii | 1 |
| 236 | titre2 | 1 |
| 237 | tlr/nlr | 1 |
| 238 | trus-estimated | 1 |
| 239 | tscherne | 1 |
| 240 | u.s.fda | 1 |
| 241 | unbeaten | 1 |
| 242 | upar-positive | 1 |
| 243 | us-apa | 1 |
| 244 | us-national | 1 |
| 245 | usaid-sponsored | 1 |
| 246 | vasodilator-associated | 1 |
| 247 | venographically-confirmed | 1 |
| 248 | witter | 1 |
| 249 | zeria | 1 |
| 250 | zor-induced | 1 |
| 251 | |δ | 1 |
| 1 | 'kanyini | 1 |
| 2 | 'salmeterol | 1 |
| 3 | -calmodulin | 1 |
| 4 | -european | 1 |
| 5 | -tonsillectomy | 1 |
| 6 | -wellbeing | 1 |
| 7 | 0.28±0.15 | 1 |
| 8 | 10,164 | 1 |
| 9 | 11-ketobetamethasone | 1 |
| 10 | 2,100bp | 1 |
| 11 | 3-staged | 1 |
| 12 | 42a | 1 |
| 13 | 450-page | 1 |
| 14 | 8-core | 3 |
| 15 | 802.15.4 | 1 |
| 16 | 900-min | 1 |
| 17 | abbé | 2 |
| 18 | absorb-extend | 1 |
| 19 | accrediting | 7 |
| 20 | actg-019 | 1 |
| 21 | active-passive | 2 |
| 22 | adipogenically | 1 |
| 23 | african-centred | 1 |
| 24 | al-razi | 1 |
| 25 | algorithm-dependent | 1 |
| 26 | allo-transplantable | 1 |
| 27 | ambrosetti | 6 |
| 28 | amduca | 1 |
| 29 | ami-kyoto | 2 |
| 30 | amsterdam-maastricht | 2 |
| 31 | antares | 2 |
| 32 | aocmf | 3 |
| 33 | apodictic | 1 |
| 34 | arc/bsr | 1 |
| 35 | ase/eae | 1 |
| 36 | asfs-based | 1 |
| 37 | ash/asco | 6 |
| 38 | ash/ish | 1 |
| 39 | aspecct | 1 |
| 40 | atomix | 1 |
| 41 | ats/ers/jrs/alat | 4 |
| 42 | ats/idsa | 3 |
| 43 | aua/acs | 1 |
| 44 | autoset™ | 1 |
| 45 | bioinformatics-based | 1 |
| 46 | boost© | 1 |
| 47 | boryung | 1 |
| 48 | breath-actuator | 1 |
| 49 | brighton | 13 |
| 50 | böstman | 1 |
| 51 | cairui | 1 |
| 52 | cal/osha | 1 |
| 53 | canchild | 1 |
| 54 | care-hd | 1 |
| 55 | ccdc3-containing | 1 |
| 56 | cd3/cd28 | 2 |
| 57 | centrewatch | 8 |
| 58 | cernea | 1 |
| 59 | chemo-induced | 1 |
| 60 | chius | 1 |
| 61 | cirs-053 | 1 |
| 62 | cochrane/trials | 1 |
| 63 | cohort—the | 1 |
| 64 | concertées | 1 |
| 65 | council/australasian | 1 |
| 66 | dejour | 1 |
| 67 | dharmarajan | 3 |
| 68 | dhew | 1 |
| 69 | diminish-ing | 1 |
| 70 | disease-centred | 1 |
| 71 | e-healing | 2 |
| 72 | e04 | 2 |
| 73 | eaaci | 7 |
| 74 | eas/esc | 1 |
| 75 | eau/esiu | 1 |
| 76 | ebewe | 1 |
| 77 | efmann | 1 |
| 78 | efsumb | 1 |
| 79 | eight-class | 1 |
| 80 | ensembl | 7 |
| 81 | erspc-affiliated | 1 |
| 82 | essex-lopresti | 4 |
| 83 | eurocat | 3 |
| 84 | eurofins | 2 |
| 85 | evans-jensen | 3 |
| 86 | examiner-reported | 1 |
| 87 | existingcholesterol | 1 |
| 88 | expository | 3 |
| 89 | fife | 6 |
| 90 | folated | 4 |
| 91 | french-american-british | 11 |
| 92 | friville | 1 |
| 93 | ftc/international | 1 |
| 94 | g=-3.36 | 1 |
| 95 | geographycally | 1 |
| 96 | getgoal | 3 |
| 97 | gina/nih | 1 |
| 98 | gish | 3 |
| 99 | glucksberg | 1 |
| 100 | goh | 2 |
| 101 | grelan | 1 |
| 102 | grundartangi | 1 |
| 103 | guelrud | 1 |
| 104 | h-delta | 1 |
| 105 | haddad | 5 |
| 106 | hand-action | 1 |
| 107 | heath-edwards | 2 |
| 108 | hemis | 1 |
| 109 | hew | 3 |
| 110 | hf/hf-fed | 1 |
| 111 | hinkle | 1 |
| 112 | histogenic | 1 |
| 113 | hohenheim | 4 |
| 114 | hormone-naive | 1 |
| 115 | hospital/industry | 2 |
| 116 | hospitals/ucl | 1 |
| 117 | hypertensive-hypercholesterolemic | 1 |
| 118 | hypolyte | 3 |
| 119 | ic3d | 1 |
| 120 | ich-gcp | 6 |
| 121 | ideal32 | 1 |
| 122 | idsa/ats | 3 |
| 123 | ihpba | 1 |
| 124 | iii-phase | 1 |
| 125 | industry-independent | 5 |
| 126 | inter-national | 3 |
| 127 | interagency | 41 |
| 128 | intercontinental | 10 |
| 129 | international | 9,309 |
| 130 | isrctn16968287 | 1 |
| 131 | italian-american | 2 |
| 132 | iuga-ics | 4 |
| 133 | jackknifed | 1 |
| 134 | jeog | 4 |
| 135 | jetf | 1 |
| 136 | joints-the | 1 |
| 137 | keith-wagener | 2 |
| 138 | kinase/phosphatase | 1 |
| 139 | klossner | 1 |
| 140 | koval | 1 |
| 141 | kudo | 4 |
| 142 | laporta | 1 |
| 143 | lasker-debakey | 1 |
| 144 | lasker~debakey | 1 |
| 145 | levels-national | 1 |
| 146 | licl-induced | 6 |
| 147 | lipididiet | 1 |
| 148 | longitudinale | 2 |
| 149 | lung-cell | 2 |
| 150 | m2182 | 1 |
| 151 | mechanismsof | 1 |
| 152 | mediafinder®-standard | 1 |
| 153 | medline/relevant | 1 |
| 154 | meshs | 1 |
| 155 | methyldopa+thiazides | 1 |
| 156 | micro-cares | 1 |
| 157 | micturition/international | 1 |
| 158 | morphological-based | 1 |
| 159 | morris-marshall | 4 |
| 160 | movahed | 1 |
| 161 | msmart | 1 |
| 162 | mt-driven | 1 |
| 163 | multi-value | 2 |
| 164 | murgo | 1 |
| 165 | national/international | 11 |
| 166 | nausea-induced | 1 |
| 167 | ncep-atp3 | 1 |
| 168 | nci-sponsored | 2 |
| 169 | nei-sponsored | 1 |
| 170 | nidcr-funded | 2 |
| 171 | nmes-evoked | 1 |
| 172 | non-medline | 7 |
| 173 | nrtis+a | 1 |
| 174 | nsclc∶ | 1 |
| 175 | nuys | 4 |
| 176 | oligarchic | 3 |
| 177 | oncology-taiho | 1 |
| 178 | onycoe-t. | 1 |
| 179 | organisation-esmo-european | 1 |
| 180 | organisation-european | 1 |
| 181 | organises | 1 |
| 182 | overdiagnosis-themed | 1 |
| 183 | oyedeji | 1 |
| 184 | patient-choice | 2 |
| 185 | patient-simulated | 1 |
| 186 | patriotic | 3 |
| 187 | pauwels | 1 |
| 188 | pennington | 5 |
| 189 | pharmachologically | 1 |
| 190 | pharmacuetical | 1 |
| 191 | pharmetrics | 11 |
| 192 | phpt-2 | 1 |
| 193 | polimorphous | 1 |
| 194 | practice-selected | 1 |
| 195 | progesterone-rich | 1 |
| 196 | pseudonymous | 1 |
| 197 | pth-levels | 1 |
| 198 | qualis | 6 |
| 199 | racgp | 1 |
| 200 | rayhack | 1 |
| 201 | re-developed | 1 |
| 202 | re-search | 1 |
| 203 | region-appropriate | 1 |
| 204 | regnauld | 1 |
| 205 | reichek | 2 |
| 206 | resolute-korea | 1 |
| 207 | ridley-jopling | 1 |
| 208 | sakakibara | 1 |
| 209 | sakita-miwa | 1 |
| 210 | sepulveda | 3 |
| 211 | shimada | 2 |
| 212 | siopel-3 | 1 |
| 213 | six-randomized | 1 |
| 214 | slnb-based | 1 |
| 215 | smillie | 1 |
| 216 | staff-derived | 4 |
| 217 | standard-observer | 1 |
| 218 | still-evolving | 1 |
| 219 | stroke-funded | 1 |
| 220 | stulberg | 1 |
| 221 | surgical-pathological | 2 |
| 222 | t2n1 | 2 |
| 223 | taisho | 1 |
| 224 | task-force | 1 |
| 225 | theradoc™ | 1 |
| 226 | third-edition | 1 |
| 227 | time-cycled | 7 |
| 228 | time-international | 2 |
| 229 | time/international | 3 |
| 230 | timi-iii | 1 |
| 231 | titre2 | 1 |
| 232 | tlr/nlr | 1 |
| 233 | trus-estimated | 1 |
| 234 | tscherne | 1 |
| 235 | u.k.-based | 4 |
| 236 | u.s.fda | 1 |
| 237 | ukpid | 2 |
| 238 | unbeaten | 1 |
| 239 | upar-positive | 1 |
| 240 | us-apa | 1 |
| 241 | us-national | 1 |
| 242 | usaid-sponsored | 1 |
| 243 | vasodilator-associated | 1 |
| 244 | venographically-confirmed | 1 |
| 245 | wcrf/aicr | 5 |
| 246 | well-publicized | 8 |
| 247 | who/isgyp | 2 |
| 248 | witter | 1 |
| 249 | zeria | 1 |
| 250 | zor-induced | 1 |
| 251 | |δ | 1 |
| 1 | onycoe-t. | 1 |
| 2 | t2n1 | 2 |
| 3 | phpt-2 | 1 |
| 4 | ideal32 | 1 |
| 5 | m2182 | 1 |
| 6 | titre2 | 1 |
| 7 | siopel-3 | 1 |
| 8 | cirs-053 | 1 |
| 9 | ncep-atp3 | 1 |
| 10 | 802.15.4 | 1 |
| 11 | e04 | 2 |
| 12 | 10,164 | 1 |
| 13 | 0.28±0.15 | 1 |
| 14 | g=-3.36 | 1 |
| 15 | isrctn16968287 | 1 |
| 16 | cd3/cd28 | 2 |
| 17 | actg-019 | 1 |
| 18 | nrtis+a | 1 |
| 19 | 42a | 1 |
| 20 | ihpba | 1 |
| 21 | amduca | 1 |
| 22 | shimada | 2 |
| 23 | sepulveda | 3 |
| 24 | u.s.fda | 1 |
| 25 | cernea | 1 |
| 26 | resolute-korea | 1 |
| 27 | cal/osha | 1 |
| 28 | zeria | 1 |
| 29 | us-apa | 1 |
| 30 | sakakibara | 1 |
| 31 | ats/idsa | 3 |
| 32 | h-delta | 1 |
| 33 | laporta | 1 |
| 34 | sakita-miwa | 1 |
| 35 | efsumb | 1 |
| 36 | oligarchic | 3 |
| 37 | hypertensive-hypercholesterolemic | 1 |
| 38 | histogenic | 1 |
| 39 | apodictic | 1 |
| 40 | patriotic | 3 |
| 41 | eas/esc | 1 |
| 42 | ic3d | 1 |
| 43 | haddad | 5 |
| 44 | nausea-induced | 1 |
| 45 | licl-induced | 6 |
| 46 | chemo-induced | 1 |
| 47 | zor-induced | 1 |
| 48 | stroke-funded | 1 |
| 49 | nidcr-funded | 2 |
| 50 | hf/hf-fed | 1 |
| 51 | jackknifed | 1 |
| 52 | 3-staged | 1 |
| 53 | movahed | 1 |
| 54 | nmes-evoked | 1 |
| 55 | time-cycled | 7 |
| 56 | overdiagnosis-themed | 1 |
| 57 | venographically-confirmed | 1 |
| 58 | re-developed | 1 |
| 59 | usaid-sponsored | 1 |
| 60 | nci-sponsored | 2 |
| 61 | nei-sponsored | 1 |
| 62 | disease-centred | 1 |
| 63 | african-centred | 1 |
| 64 | u.k.-based | 4 |
| 65 | slnb-based | 1 |
| 66 | morphological-based | 1 |
| 67 | bioinformatics-based | 1 |
| 68 | asfs-based | 1 |
| 69 | vasodilator-associated | 1 |
| 70 | erspc-affiliated | 1 |
| 71 | folated | 4 |
| 72 | patient-simulated | 1 |
| 73 | trus-estimated | 1 |
| 74 | practice-selected | 1 |
| 75 | examiner-reported | 1 |
| 76 | staff-derived | 4 |
| 77 | well-publicized | 8 |
| 78 | six-randomized | 1 |
| 79 | care-hd | 1 |
| 80 | ukpid | 2 |
| 81 | canchild | 1 |
| 82 | regnauld | 1 |
| 83 | absorb-extend | 1 |
| 84 | mediafinder®-standard | 1 |
| 85 | guelrud | 1 |
| 86 | ase/eae | 1 |
| 87 | patient-choice | 2 |
| 88 | task-force | 1 |
| 89 | fife | 6 |
| 90 | 450-page | 1 |
| 91 | joints-the | 1 |
| 92 | cohort—the | 1 |
| 93 | smillie | 1 |
| 94 | longitudinale | 2 |
| 95 | allo-transplantable | 1 |
| 96 | hinkle | 1 |
| 97 | friville | 1 |
| 98 | non-medline | 7 |
| 99 | 11-ketobetamethasone | 1 |
| 100 | tscherne | 1 |
| 101 | 8-core | 3 |
| 102 | iii-phase | 1 |
| 103 | kinase/phosphatase | 1 |
| 104 | region-appropriate | 1 |
| 105 | hypolyte | 3 |
| 106 | multi-value | 2 |
| 107 | hormone-naive | 1 |
| 108 | active-passive | 2 |
| 109 | upar-positive | 1 |
| 110 | ebewe | 1 |
| 111 | aocmf | 3 |
| 112 | mechanismsof | 1 |
| 113 | jetf | 1 |
| 114 | diminish-ing | 1 |
| 115 | -wellbeing | 1 |
| 116 | e-healing | 2 |
| 117 | ridley-jopling | 1 |
| 118 | ccdc3-containing | 1 |
| 119 | accrediting | 7 |
| 120 | still-evolving | 1 |
| 121 | boryung | 1 |
| 122 | jeog | 4 |
| 123 | stulberg | 1 |
| 124 | glucksberg | 1 |
| 125 | progesterone-rich | 1 |
| 126 | re-search | 1 |
| 127 | centrewatch | 8 |
| 128 | gina/nih | 1 |
| 129 | goh | 2 |
| 130 | ash/ish | 1 |
| 131 | gish | 3 |
| 132 | french-american-british | 11 |
| 133 | eaaci | 7 |
| 134 | grundartangi | 1 |
| 135 | timi-iii | 1 |
| 136 | oyedeji | 1 |
| 137 | 'kanyini | 1 |
| 138 | essex-lopresti | 4 |
| 139 | ambrosetti | 6 |
| 140 | cairui | 1 |
| 141 | al-razi | 1 |
| 142 | rayhack | 1 |
| 143 | reichek | 2 |
| 144 | surgical-pathological | 2 |
| 145 | pharmacuetical | 1 |
| 146 | inter-national | 3 |
| 147 | levels-national | 1 |
| 148 | us-national | 1 |
| 149 | international | 9,309 |
| 150 | time-international | 2 |
| 151 | ftc/international | 1 |
| 152 | time/international | 3 |
| 153 | national/international | 11 |
| 154 | micturition/international | 1 |
| 155 | getgoal | 3 |
| 156 | intercontinental | 10 |
| 157 | koval | 1 |
| 158 | ensembl | 7 |
| 159 | hospitals/ucl | 1 |
| 160 | morris-marshall | 4 |
| 161 | lung-cell | 2 |
| 162 | 'salmeterol | 1 |
| 163 | existingcholesterol | 1 |
| 164 | hohenheim | 4 |
| 165 | italian-american | 2 |
| 166 | -european | 1 |
| 167 | organisation-european | 1 |
| 168 | organisation-esmo-european | 1 |
| 169 | council/australasian | 1 |
| 170 | dharmarajan | 3 |
| 171 | grelan | 1 |
| 172 | böstman | 1 |
| 173 | evans-jensen | 3 |
| 174 | unbeaten | 1 |
| 175 | mt-driven | 1 |
| 176 | -calmodulin | 1 |
| 177 | 900-min | 1 |
| 178 | efmann | 1 |
| 179 | hand-action | 1 |
| 180 | third-edition | 1 |
| 181 | pennington | 5 |
| 182 | brighton | 13 |
| 183 | ash/asco | 6 |
| 184 | kudo | 4 |
| 185 | murgo | 1 |
| 186 | oncology-taiho | 1 |
| 187 | taisho | 1 |
| 188 | ami-kyoto | 2 |
| 189 | 2,100bp | 1 |
| 190 | ich-gcp | 6 |
| 191 | racgp | 1 |
| 192 | who/isgyp | 2 |
| 193 | wcrf/aicr | 5 |
| 194 | keith-wagener | 2 |
| 195 | klossner | 1 |
| 196 | witter | 1 |
| 197 | standard-observer | 1 |
| 198 | tlr/nlr | 1 |
| 199 | breath-actuator | 1 |
| 200 | arc/bsr | 1 |
| 201 | dejour | 1 |
| 202 | aua/acs | 1 |
| 203 | iuga-ics | 4 |
| 204 | pharmetrics | 11 |
| 205 | heath-edwards | 2 |
| 206 | methyldopa+thiazides | 1 |
| 207 | micro-cares | 1 |
| 208 | antares | 2 |
| 209 | organises | 1 |
| 210 | concertées | 1 |
| 211 | meshs | 1 |
| 212 | qualis | 6 |
| 213 | hemis | 1 |
| 214 | cochrane/trials | 1 |
| 215 | pth-levels | 1 |
| 216 | pauwels | 1 |
| 217 | eurofins | 2 |
| 218 | eight-class | 1 |
| 219 | idsa/ats | 3 |
| 220 | chius | 1 |
| 221 | polimorphous | 1 |
| 222 | pseudonymous | 1 |
| 223 | nuys | 4 |
| 224 | eurocat | 3 |
| 225 | ats/ers/jrs/alat | 4 |
| 226 | aspecct | 1 |
| 227 | lipididiet | 1 |
| 228 | amsterdam-maastricht | 2 |
| 229 | medline/relevant | 1 |
| 230 | algorithm-dependent | 1 |
| 231 | industry-independent | 5 |
| 232 | msmart | 1 |
| 233 | eau/esiu | 1 |
| 234 | hew | 3 |
| 235 | dhew | 1 |
| 236 | atomix | 1 |
| 237 | interagency | 41 |
| 238 | lasker-debakey | 1 |
| 239 | lasker~debakey | 1 |
| 240 | pharmachologically | 1 |
| 241 | adipogenically | 1 |
| 242 | geographycally | 1 |
| 243 | -tonsillectomy | 1 |
| 244 | expository | 3 |
| 245 | hospital/industry | 2 |
| 246 | theradoc™ | 1 |
| 247 | autoset™ | 1 |
| 248 | boost© | 1 |
| 249 | abbé | 2 |
| 250 | |δ | 1 |
| 251 | nsclc∶ | 1 |